Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis?
Wim Jiskoot(Diagnostics for the Real World (United Kingdom)), Daan J.A. Crommelin(Utrecht University)
Cited by 104
Related Papers
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
|International Journal of Pharmaceutics|2021|1.4k
Extrinsic Fluorescent Dyes as Tools for Protein Characterization
|Pharmaceutical Research|2008|1.2k